Effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after acute myocardial infarction

Zhang,Yingchun; Zhang,Lingzhi; Zheng,Hongzhi Zheng; Chen,Hongfen

doi:10.3892/etm.2018.6640

Effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after acute myocardial infarction

Authors:
- Yingchun Zhang
- Lingzhi Zhang
- Hongzhi Zheng Zheng
- Hongfen Chen
View Affiliations

Affiliations: Department of Emergency, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China, Department of Stomatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China, Department of Public Health, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China
Published online on: August 22, 2018 https://doi.org/10.3892/etm.2018.6640
Pages: 3574-3578
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The effects of atrial fibrillation on complications and prognosis of patients receiving emergency percutaneous coronary intervention after acute myocardial infarction (AMI) were investigated. Eighty AMI patients treated with interventional vascular recanalization in the Affiliated Hospital of Weifang Medical University (Weifang, China) from July 2015 to October 2016 were selected, including 40 patients complicated with atrial fibrillation before operation (control group) and 40 patients without atrial fibrillation before operation (observation group). The systolic blood pressure, diastolic blood pressure, heart rate, arrhythmia and common complications after MI were compared. Changes in the coronary artery thrombolysis in myocardial infarction (TIMI) flow grade and left ventricular ejection fraction (LVEF) of patients were also recorded. Moreover, changes in brain natriuretic peptide (BNP) levels were compared. The recovery time of myocardial enzyme and total troponin in both groups was recorded. The systolic and diastolic blood pressure in the observation group were significantly higher than those in the control group (p<0.05). During the intervention, the total proportion of patients with ventricular arrhythmia, atrial arrhythmia, atrioventricular block and sinus tachycardia in the observation group was significantly lower than that in the control group (p<0.05). The total proportion of common complications after MI in the observation group was obviously lower than that in the control group (p<0.05). Coronary artery TIMI flow grades and LVEFs in the observation group were obviously higher than those in the control group. BNP levels in the observation group were significantly lower than those in the control group. The recovery time of myocardial enzyme and total troponin in the observation group was significantly earlier than that in the control group. Atrial fibrillation has a certain negative effect on the circulatory function in patients with AMI after the interventional therapy, and the proportions of arrhythmia and complications in patients after MI are increased at the same time, so the postoperative recovery of patients is slow with many complications.

View Figures

View References

1	Batra G, Friberg L, Erlinge D, James S, Jernberg T, Svennblad B, Wallentin L and Oldgren J: Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention. Eur Heart J Cardiovasc Pharmacother. 6:36–45. 2018. View Article : Google Scholar
2	Chen J, Wang LY, Deng C, Jiang XH and Chen TG: The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis. Medicine (Baltimore). 96:e80152017.https://doi.org/10.1097/MD.0000000000008015simple10.1097/MD.0000000000008015 View Article : Google Scholar : PubMed/NCBI
3	Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, et al: RE-DUAL PCI Steering Committee and Investigators: Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 377:1513–1524. 2017. View Article : Google Scholar : PubMed/NCBI
4	Hwang KK, Eom SY, Lee SY, Kim SM, Cho MC, Kim YJ, Seung KB, Jeong MH and Bae JW; other Korea Acute Myocardial Infarction Registry Investigators, : Atrial fibrillation on admission is related with higher mortality in ST-segment elevation myocardial infarction patients. Int Heart J. 58:486–494. 2017. View Article : Google Scholar : PubMed/NCBI
5	Zhai HB, Liu J, Dong ZC, Wang DX and Zhang B: Current use of oral anticoagulants and prognostic analysis in patients with atrial fibrillation undergoing coronary stenting. Chin Med J (Engl). 130:1418–1423. 2017. View Article : Google Scholar : PubMed/NCBI
6	Ispas AF, Mangin L, Paziuc A and Belle L: Unexpected evolution of a non-stenotic lesion in the left main coronary artery of a patient with non-ST-segment elevation myocardial infarction. Cardiovasc Diagn Ther. 7:340–344. 2017. View Article : Google Scholar : PubMed/NCBI
7	Choi HI, Ahn JM, Kang SH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, et al: Prevalence, management, and long-term (6-year) outcomes of atrial fibrillation among patients receiving drug-eluting coronary stents. JACC Cardiovasc Interv. 10:1075–1085. 2017. View Article : Google Scholar : PubMed/NCBI
8	Topaz G, Flint N, Steinvil A, Finkelstein A, Banai S, Keren G, Shacham Y and Yankelson L: Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention. Int J Cardiol. 240:228–233. 2017. View Article : Google Scholar : PubMed/NCBI
9	Gwyn JCV, Thomas MR and Kirchhof P: Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: A viewpoint. Eur Heart J Cardiovasc Pharmacother. 3:157–162. 2017. View Article : Google Scholar : PubMed/NCBI
10	Romanov A, Martinek M, Pürerfellner H, Chen S, De Melis M, Grazhdankin I, Ponomarev D, Losik D, Strelnikov A, Shabanov V, et al: Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: Results of the ARREST study. Europace. 20:263–270. 2018. View Article : Google Scholar : PubMed/NCBI
11	Bogacki P, Kabłak-Ziembicka A, Bryniarski K, Wrotniak L, Ostrowska-Kaim E, Żmudka K and Przewłocki T: Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment. Postepy Kardiol Interwencyjnej. 12:303–313. 2016.PubMed/NCBI
12	Chaudhary N, Bundhun PK and Yan H: Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies. Medicine (Baltimore). 95:e55812016. View Article : Google Scholar : PubMed/NCBI
13	Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, et al: Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 375:2423–2434. 2016. View Article : Google Scholar : PubMed/NCBI
14	Zehir R, Tekkesin AI, Haykir N, Velibey Y, Borklu EB and Gumusdag A: Peak troponin I level predicts new-onset atrial fibrillation in patients with myocardial infarction. Clin Invest Med. 39:E213–E219. 2016. View Article : Google Scholar : PubMed/NCBI
15	Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E and Airaksinen J: Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: A nationwide cohort study from Finland. BMJ Open. 6:e0126042016. View Article : Google Scholar : PubMed/NCBI
16	Bagai A, Wang TY, Goodman SG, Fisher HN, Welsh RC, Dery JP, Zhang X, Zhu YE, Cheema AN, Dehghani P, et al: Canadian Observational AntiPlatelet sTudy (COAPT) Investigators: Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy. Int J Cardiol. 228:459–464. 2017. View Article : Google Scholar : PubMed/NCBI
17	Cannon CP, Gropper S, Bhatt DL, Ellis SG, Kimura T, Lip GY, Steg PG, Ten Berg JM, Manassie J, Kreuzer J, et al: RE-DUAL PCI Steering Committee and Investigators: Design and Rationale of the RE-DUAL PCI Trial: A prospective, randomized, phase 3b study comparing the safety and efficacy of dual antithrombotic therapy with dabigatran etexilate versus warfarin triple therapy in patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stenting. Clin Cardiol. 39:555–564. 2016. View Article : Google Scholar : PubMed/NCBI
18	Dekkers OM, Horváth-Puhó E, Cannegieter SC, Vandenbroucke JP, Sørensen HT and Jørgensen JO: Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: A population-based cohort study. Eur J Endocrinol. 176:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
19	Hudzik B, Szkodziński J, Hawranek M, Lekston A, Poloński L and Gąsior M: CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation. Acta Diabetol. 53:807–815. 2016. View Article : Google Scholar : PubMed/NCBI
20	Masuda M, Nakatani D, Hikoso S, Suna S, Usami M, Matsumoto S, Kitamura T, Minamiguchi H, Okuyama Y, Uematsu M, et al: OACIS Investigators: Clinical impact of ventricular tachycardia and/or fibrillation during the acute phase of acute myocardial infarction on in-hospital and 5-year mortality rates in the percutaneous coronary intervention era. Circ J. 80:1539–1547. 2016. View Article : Google Scholar : PubMed/NCBI